Novartis India Strategic Review: Impact on Listed Business
February 16, 2024 22:31
Novartis AG announces a strategic review of Novartis India Ltd, its listed subsidiary, assessing its 70.68% shareholding. The review does not impact Novartis Healthcare Pvt Ltd.